SCHEMBL19494635

SCHEMBL19494635

NC(=O)c1cc(NN2CCOCC2)sc1NC(=O)c1ncco1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 2/20 0.35
▸ IKBKE Q14164 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ MAPT P10636 5/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ HPGD P15428 3/20 0.34
▸ ALOX15 P16050 3/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ MAPK10 P53779 3/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ USP2 O75604 3/20 0.34
▸ CFTR P13569 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16338254 0.80 CFTR (0.53) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL19494633 0.79 ALDH1A1 (0.33) TBK1IKBKEALDH1A1MAPTKDM4E
SCHEMBL18044891 0.67 CFTR (0.39) CFTRKCNH2CHEK1
SCHEMBL16338427 0.64 CFTR (0.56) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL16246521 0.62 KMT2A (0.57) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL16246308 0.62 CFTR (0.53) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL16246489 0.62 CFTR (0.52) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL6700332 0.61 PIK3CA (0.45) MAPTKDM4EMEN1KMT2AHSD17B10
SCHEMBL16246404 0.61 TSHR (0.57) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL16246490 0.60 CFTR (0.51) ALDH1A1MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback